Alto Group Holdings, Inc. ALTO 深 滬
已收盤 12-12 16:00:00 美东时间
2.50
-0.060
-2.34%
華盛通- 最 高2.595
- 今 開2.55
- 成交量 83.92万股
- 最 低 2.45
- 昨 收 2.56
- 總市值 1.93亿
- 52周最高 2.92
- 市盈率 靜 --
- 換手率 1.08%
- 52周最低 0.76
- 委 比 66.99%
- 總股本 7739.77万
- 歷史最高 23.969
- 量 比 0.58
- 振 幅 5.66%
- 歷史最低 0.22
- 每 手 1
- 風險率 0.41%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Why Snap Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
Shares of Snap Inc (NYSE:SNAP) rose sharply in pre-market trading after the com...
11-06 19:32
Why Did Alto Ingredients Stock Pop 38% After Hours?
Alto Ingredients' stock surged 38% in after-hours trading following a profitable third-quarter earnings report.
11-06 13:17
Alto Ingredients shares are trading higher after the company beat Q3 earnings and revenue estimates.
Alto Ingredients shares are trading higher after the company beat Q3 earnings a...
11-06 06:05
Alto Ingredients Q3 EPS $0.19 Beats $(0.06) Estimate, Sales $241.000M Beat $235.684M Estimate
Alto Ingredients (NASDAQ:ALTO) reported quarterly earnings of $0.19 per share which beat the analyst consensus estimate of $(0.06) by 445.45 percent. This is a 575 percent increase over losses of $(0.04) per share from
11-06 05:24
Earnings Scheduled For November 5, 2025
Companies Reporting Before The Bell • Avient (NYSE:AVNT) is estimated to report...
11-05 19:12
Kalaris to Present at Stifel 2025 Annual Healthcare Conference
Kalaris Therapeutics announced that its management, including CEO Andrew Oxtoby and CMO Matthew Feinsod, will present at the Stifel 2025 Annual Healthcare Conference on November 13, 2025, from 3:20 – 3:50pm ET at the Lotte New York Palace Hotel. The company, focused on developing treatments for retinal diseases like nAMD, DME, and RVO, will also offer one-on-one meetings for interested parties during the event.
10-30 12:00
Cognizant And Rubrik Partner To Launch AI-Driven Business Resilience-As-A-Service To Combat Ransomware And Cyber Threats
Partnership advances outcome-based cyber resilience, combining AI-driven security and global scale to move from reactive recovery to proactive resilience.TEANECK, N.J. and PALO ALTO, Calif., Oct. 27, 2025
10-27 20:17
Alto Neuroscience secures $50M in PIPE financing
Alto Neuroscience (NYSE:ANRO) has announced that it has secured approximately $50 million in gross proceeds through a private investment in public equity (PIPE) financing. The $50 million PIPE involv...
10-20 19:42
Alto Neuroscience Announces $50M Private Placement To Accelerate Development Of ALTO-207 In Treatment Resistant Depression
– Financing led by Perceptive Advisors with participation from new and existing biotech focused investors –– Alto expects to use the proceeds of this financing to accelerate development of ALTO-207 in Treatment Resistant
10-20 19:12
Cloudastructure Board Approves Up To $5M Stock Buyback Plan
PALO ALTO, CA, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Cloudastructure, Inc. (NASDAQ:CSAI) ("we," "us," "our," "Cloudastructure" or the "Company"), a recognized leader in AI Surveillance and Remote Guarding, today announced
10-16 20:35
